Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma

American Journal of Neuroradiology

Volumn 33, Issue 1, 2012, Pages 69-76

  Hu, Leland S ^a,b   Eschbacher, J M ^b   Dueck, A C ^a   Heiserman, J E ^b   Liu, S ^b   Karis, J P ^b   Smith, K A ^b   Shapiro, W R ^b   Pinnaduwage, D S ^b,c   Coons, S W ^b   Nakaji, P ^b   Debbins, J ^b   Feuerstein, B G ^b   Baxter, L C ^b  

^a MAYO CLINIC   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADODIAMIDE;

ARTICLE; BRAIN BLOOD VESSEL; BRAIN BLOOD VOLUME; BRAIN PERFUSION; BRAIN TUMOR; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DYNAMIC SUSCEPTIBILITY WEIGHTED CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; GLIOMA; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; QUANTITATIVE ANALYSIS; STEREOTACTIC BIOPSY; STEREOTACTIC PROCEDURE; STEREOTAXIC SURGERY; TUMOR RECURRENCE;

ADULT; BLOOD VOLUME DETERMINATION; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 84862908602     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2743     Document Type: Article

References (51)

1. Sharma S, Sharma MC, Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005;46:481-89 (Pubitemid 40632304)
2. Schiffer D, Chio A, Mauro GA, et a. The vascular response to tumor infiltration in malignant gliomas. Acta Neuropathol 1989;77:369-78
3. Abdulrauf SI, Edvardsen K, Ho KL, et al. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998;88:513-20 (Pubitemid 28114725)
4. Korkolopoulou P, Patsouris E, Kavantzas N, et al. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 2002;28:57-66 (Pubitemid 34175513)
5. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362-72 (Pubitemid 26023356)
6. Wesseling P, van der Laak JA, Link M, et al. Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. Hum Pathol 1998;29:352-28
7. Wesseling P, van der Laak JA, de Leeuw H, et al. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme: computer-assisted image analysis of whole-tumor sections. J Neurosurg 1994;81:902-09 (Pubitemid 24373471)
8. Birner P, Piribauer M, Fischer I, et al. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes. Brain Pathol 2003;13:133-43 (Pubitemid 36460814)
9. Folkerth RD. Histologic measures of angiogenesis in human primary brain tumors. Cancer Treat Res 2004;117:79-95
10. Korkolopoulou P, Patsouris E, Konstantinidou AE, et al. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis. Neuropathol Appl Neurobiol 2004;30:267-78 (Pubitemid 38789248)
11. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
12. Macchiarini P, Fontaini G, Hardin MJ, et al. Relation of neovasculature to metastasis of non-small lung cancer. Lancet 1992;340:145-46
13. Hollingsworth HC, Kohn EC, Steinberg SM, et al. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 1995;147:33
14. Bono AV, Celato N, Cova V, et al. Microvessel density in prostate carcinoma. Prostate Cancer Prostatic Dis 2002;5:123-27 (Pubitemid 34777895)
15. Delahunt B, Bethwaite PB, Thornton A. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br J Urol 1997;80:401-04 (Pubitemid 28312844)
16. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol 2004;25:214-21 (Pubitemid 38235298)
17. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791-98 (Pubitemid 29249482)
18. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859-67 (Pubitemid 44897737)
19. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989-98 (Pubitemid 37444849)
20. Law M, Young RJ, Babb JS, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490-98. Epub 2008 Mar 18
21. Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003;49:848-55 (Pubitemid 36523471)
22. Pathak AP, Schmainda KM, Ward BD, et al. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Magn Reson Med 2001;46:735-47 (Pubitemid 32906143)
23. Ali MM, Janic B, Babajani-Feremi A, et al. Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma. PLoS One 2010;5:e8727
24. Muruganandham M, Lupu M, Dyke JP, et al. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T. Mol Cancer Ther 2006;5:1950-57 (Pubitemid 44336566)
25. Wilmes LJ, Pallavicini MG, Fleming LM, et al. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging 2007;25:319-27 (Pubitemid 46413652)
26. Hyodo F, Chandramouli GV, Matsumoto S, et al. Estimation of tumor microvessel density by MRI using a blood pool contrast agent. Int J Oncol 2009;35:797-804
27. Drevs J, Müller-Driver R, Wittig C, et al. PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. Cancer Res 2002;62:4015-22 (Pubitemid 34791068)
28. Badruddoja MA, Krouwer HG, Rand SD, et al. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro Oncol 2003;5:235-43 (Pubitemid 37265903)
29. Doblas S, He T, Saunders D, et al. Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography. J Magn Reson Imaging 2010;32: 267-75
30. Sorensen AG. Perfusion MR imaging: moving forward. Radiology 2008;249:416-17
31. Hu LS, Baxter LC, Pinnaduwage DS, et al. Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol 2010;31:40-48
32. Paulson ES, Schmainda KM. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008;249:601-13
33. Manka C, Traber F, Gleseke J, et al. Three-dimensional dynamic susceptibility weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose. Radiology 2005;234:869-77 (Pubitemid 40250831)
34. Hu LS, Baxter LC, Smith KA, et al. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 2009;30:552-58
35. Stadlbauer A, Ganslandt O, Buslei R, et al. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 2006;240:803-10 (Pubitemid 44267338)
36. Sadeghi N, Salmon I, Decaestecker C, et al. Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. AJNR Am J Neuroradiol 2007;28:455-61 (Pubitemid 46481882)
37. Louis DN, Ohgaki H, Wiestler OD, et al., eds. WHO classification of tumours of the central nervous system. Lyon, France: IARC; 2002
38. Haris M, Husain N, Singh A, et al. Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma. J Comput Assist Tomogr 2008;32:955-65
39. Winkler F, Kozin SV, Tong RT, et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004;6:553-63 (Pubitemid 40017699)
40. Weibel ER. Estimation of Basic Stereologic Parameters: Theoretical Foundations of Stereology. Vol. 2. London, UK: Academic Press; 1980
41. Liao W, Liu Y, Wang X, et al. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009;50:217-25
42. Bisdas S, Kirkpatrick M, Giglio P, et al. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? AJNR Am J Neuroradiol 2009;30:681-88
43. Hirai T, Murakami R, Nakamura H, et al. Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study. AJNR Am J Neuroradiol 2008;29:1505-10
44. Jackson RJ, Fuller GN, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol 2001;3:193-200 (Pubitemid 33674111)
45. Young GS, Setayesh K. Spin-echo echo-planar perfusion MR imaging in the differential diagnosis of solitary enhancing brain lesions: distinguishing solitary metastases from primary glioma. AJNR Am J Neuroradiol 2009;30:575-77
46. Schmainda KM, Rand SD, Joseph AM, et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 2004;25:1524-32 (Pubitemid 44383603)
47. Kassner A, Annesley DJ, Zhu XP, et al. Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging 2000;11:103-13 (Pubitemid 30080962)
48. Emblem KE, Nedregaard B, Nome T, et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008;247:808-17
49. Gijtenbeek JM, Wesseling P, Maass C, et al. Three-dimensional reconstruction of tumor microvasculature: simultaneous visualization of multiple components in paraffin-embedded tissue. Angiogenesis 2005;8:297-305
50. Rowley HA, Scialfa G, Gao PY, et al. Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide. AJNR Am J Neuroradiol 2008;29:1684-91
51. Poetker DM, Jursinic PA, Runge-Samuelson CL, et al. Distortion of magnetic resonance images used in gamma knife radiosurgery treatment planning: implications for acoustic neuroma outcomes. Otol Neurotol 2005;26:1220-28 (Pubitemid 41697382)